Literature DB >> 21181120

Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear.

Olivier Deschaux1, Guillaume Spennato, Jean-Luc Moreau, René Garcia.   

Abstract

RATIONALE: We have recently shown that post-extinction exposure of rats to a sub-threshold reminder shock can reactivate extinguished context-related freezing and found that chronic treatment with fluoxetine before fear extinction prevents this phenomenon.
OBJECTIVES: In the present study, we examined whether these findings would be confirmed with auditory fear conditioning.
METHODS: Rats were initially submitted to a session of five tone-shock pairings with either a 0.7- or 0.1-mA shock and underwent, 3 days later, a session of 20 tone-alone trials.
RESULTS: At the beginning of this latter session, we observed cue-conditioned freezing in rats that received the strong, but not the weak, shock. At the end, both groups (strong and weak shocks) displayed similar low levels of freezing, indicating fear extinction in rats exposed to the strong shock. These rats exhibited again high levels of cue-evoked freezing when exposed to three tone-shock pairings with 0.1-mA shock. This reemergence of cue-conditioned fear was completely abolished by chronic (over a 21-day period) fluoxetine treatment which spared, when administered before the initial fear conditioning, the original tone-shock association.
CONCLUSIONS: These data extend our previous findings and suggest that chronic fluoxetine treatment favor extinction memory by dampening the reactivation of the original tone-shock association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181120     DOI: 10.1007/s00213-010-2134-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Postextinction of conditioned fear: between two CS-related memories.

Authors:  René Garcia
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

2.  l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats.

Authors:  E Cavazzuti; A Bertolini; A V Vergoni; R Arletti; R Poggioli; A Forgione; A Benelli
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

3.  A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake.

Authors:  E Onder; U Tural; T Aker
Journal:  Eur Psychiatry       Date:  2005-06-17       Impact factor: 5.361

4.  Reinstatement of conditioned responses in human differential fear conditioning.

Authors:  Trinette Dirikx; Dirk Hermans; Debora Vansteenwegen; Frank Baeyens; Paul Eelen
Journal:  J Behav Ther Exp Psychiatry       Date:  2007-05-01

5.  Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.

Authors:  Patrizia Bianchi; Elisabetta Ciani; Sandra Guidi; Stefania Trazzi; Daniela Felice; Gabriele Grossi; Mercedes Fernandez; Alessandro Giuliani; Laura Calzà; Renata Bartesaghi
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

6.  Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study.

Authors:  K M Connor; S M Sutherland; L A Tupler; M L Malik; J R Davidson
Journal:  Br J Psychiatry       Date:  1999-07       Impact factor: 9.319

7.  Stress-induced enhancement of fear learning: an animal model of posttraumatic stress disorder.

Authors:  Vinuta Rau; Joseph P DeCola; Michael S Fanselow
Journal:  Neurosci Biobehav Rev       Date:  2005-08-10       Impact factor: 8.989

8.  Prefrontal infusion of PD098059 immediately after fear extinction training blocks extinction-associated prefrontal synaptic plasticity and decreases prefrontal ERK2 phosphorylation.

Authors:  Sandrine Hugues; Aline Chessel; Isabelle Lena; Robert Marsault; Rene Garcia
Journal:  Synapse       Date:  2006-09-15       Impact factor: 2.562

9.  Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.

Authors:  P Tucker; R Zaninelli; R Yehuda; L Ruggiero; K Dillingham; C D Pitts
Journal:  J Clin Psychiatry       Date:  2001-11       Impact factor: 4.384

10.  Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants.

Authors:  Cyril Rocher; Michael Spedding; Carmen Munoz; Thérèse M Jay
Journal:  Cereb Cortex       Date:  2004-02       Impact factor: 5.357

View more
  21 in total

1.  Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction.

Authors:  K Lebrón-Milad; A Tsareva; N Ahmed; M R Milad
Journal:  Behav Brain Res       Date:  2013-07-22       Impact factor: 3.332

2.  Post-extinction fluoxetine treatment prevents stress-induced reemergence of extinguished fear.

Authors:  Olivier Deschaux; Xigeng Zheng; Jennifer Lavigne; Ophélie Nachon; Carine Cleren; Jean-Luc Moreau; René Garcia
Journal:  Psychopharmacology (Berl)       Date:  2012-07-24       Impact factor: 4.530

Review 3.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 4.  Sex differences in fear extinction.

Authors:  E R Velasco; A Florido; M R Milad; R Andero
Journal:  Neurosci Biobehav Rev       Date:  2019-05-23       Impact factor: 8.989

5.  Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory.

Authors:  Catherine A Hartley; Morgan C McKenna; Rabia Salman; Andrew Holmes; B J Casey; Elizabeth A Phelps; Charles E Glatt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

6.  Fear erasure in mice requires synergy between antidepressant drugs and extinction training.

Authors:  Nina N Karpova; Anouchka Pickenhagen; Jesse Lindholm; Ettore Tiraboschi; Natalia Kulesskaya; Arna Agústsdóttir; Hanna Antila; Dina Popova; Yumiko Akamine; Amine Bahi; Regina Sullivan; René Hen; Liam J Drew; Eero Castrén
Journal:  Science       Date:  2011-12-23       Impact factor: 47.728

7.  Extinction retention and fear renewal in a lifetime obsessive-compulsive disorder sample.

Authors:  N C R McLaughlin; D Strong; A Abrantes; S Garnaat; A Cerny; C O'Connell; R Fadok; C Spofford; S A Rasmussen; M R Milad; B D Greenberg
Journal:  Behav Brain Res       Date:  2014-11-12       Impact factor: 3.332

Review 8.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

9.  Prefrontal single-unit firing associated with deficient extinction in mice.

Authors:  Paul J Fitzgerald; Nigel Whittle; Shaun M Flynn; Carolyn Graybeal; Courtney R Pinard; Ozge Gunduz-Cinar; Alexxai V Kravitz; Nicolas Singewald; Andrew Holmes
Journal:  Neurobiol Learn Mem       Date:  2013-11-11       Impact factor: 2.877

Review 10.  An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Biol Psychiatry       Date:  2015-06-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.